SMARCB1-deficient sinonasal carcinomas exhibit a broad morphologic and immunohistochemical spectrum, underscoring the importance of performing relevant INI1 and BRG1 immunohistochemical staining when classifying sinonasal tumors. This evidence concerns the gene SMARCA4 and nasal cavity and paranasal sinus carcinoma.